We would love to hear your thoughts about our site and services, please take our survey here.
Results of the successful PALOH study and protocol using Gendrive's AIHL test has just been published in the BMJ Open journal. Great visibility for this hugely important life-changing test for babies in ICU. No doubt the AIHL test from Genedrive will become a key and valuable product in the Genedrive catalog, starting with its release to the NHS this summer. EU and USA markets will be significant.....
https://bmjopen.bmj.com/content/11/6/e044457
There is little doubt in my mind that the formal ICMR approval, with 100% S&S, suggests that there is little reason to doubt that FDA and WHO approval will not follow in due course. Very soon I believe.
Tricky, I would certainly like to see that the assessment is complete . but I don't know where you have picked that up from? The latest WHO evaluation list I see that was published yesterday still has the Genedrive assessment review as 'in processs'?
.....is (roughly) 4 times better than non-automated PCR Covid test process, or putting it in these ways....
- 1 lab technician can process the same volume of PCR tests using the Biomek automation process as do 4 lab technicians running non-automated systems, in an 8 hour period.
- 4 times as many tests can be run in an automated Lab compared with a non-automated process, with the same number of technicians.
- For the same volume of testing, the automation of Covid diagnostic testing can release 3 out of every 4 lab technicians to run 'other' non-Covid PCR testing for the Lab.
So automation in diagnostics increases productivity, drives down resource costs and helps release available Lab resources to other diagnostic testing. So I believe the BC/Genedrive automation collaboration will have a significant impact to PCR testing for Covid, particularly USA and Europe. Fab for Genedrive!
The many points of positive news that LTHs have all been waiting for may finally be arriving....... they could be like buses - you wait ages for one to turn up then.....2 or 3 come along in quick succession. Let us hope so......
Beforegolf, don't worry about me, anyone who has followed this board for the past 8 months will know I have done my own research. I would encourage others to dyor and look back at the contributions that posters have made to determine if the position they say they hold rings true with what they have been spouting most of the time over many months.
Magsy, please accurately answer if you are holding genedrive shares and if you are please give us the reasons why you are holding.
I am pretty sure DB believes it is not too far away, although ICMR are in control of this, but there is confidence that Genedrive will get there with ICMR so cannot be long now......
This is a good sign for Genedrive testing kits being part of the opportunity in the multi billion pound UK testing programme.
u696061, the 'point of care testing' statement has been in there since before November.....here is the archive page from November 1st.....
https://web.archive.org/web/20201101065447/http://www.genedriveplc.com/investor-relations/covid19.php
Notice the statement around 'UK limited interest' from that archive page has now been removed. Today, in fact. I know this since I was looking at the page earlier this morning and this statement has now been removed.
Anyone else noticed that the statement :
"We understand that the UK has limited interest in new supply for testing kits."
has recently been removed (today) from the Covid-19 Summary document from the Investor Relations page on the Genedrive web-site.........so factors have changed.....for the better in respect of Genedrive I believe.
Just listened to Professor William Hasletine, from Harvard Medical School, on CNN. He says that US needs to get to home test LFTs as soon as possible to control the virus in the US. As an example he referred to "Britain" as ordering 2 billion LFT tests, says USA must follow same approach. I wonder who can help make these billions of LFT tests for the UK......?
"Our initial US evaluation site is currently being installed following the completion of our internal validation studies,"......tick
" after which they will validate the end-to-end solution as required"...... tick (today's tweet)
" We will obtain regulatory approvals prior to a final solution release.".....the final step, cannot be long now after the above tick in boxes......
upomega, because vaccines are not 100%, so everyone that has been vaccinated would want to know that their body has produced the necessary antibodies after vaccination, rather than just keeping their fingers crossed and hoping for the best.
immune response, not my view but the view coming from one of our RTC partners. That could be soon after any vaccine has been administered since vaccines are not 100% but also for some duration after vaccination to ensure continued immune response is there. For as long as vaccination is necessary to protect against Covid then antibody testing will be needed. That could be for many years yet.
A slow beginning right now with the RTC AbC-19 rapid antibody test but it has all the potential to grow into something very significant very soon as it goes hand-in-hand with Covid-19 vaccinations.
Michael Mina is co-author of Harvard study I posted earlier, which supports frequent rapid testing LFT to control the spread of the virus. He was also interviewed on CNN about the study, so there is a lot of interest in this approach...
https://www.hsph.harvard.edu/news/press-releases/frequent-rapid-testing-could-turn-national-covid-19-tide-within-weeks/
This study was also reported on CNN news today.
https://www.hsph.harvard.edu/news/press-releases/frequent-rapid-testing-could-turn-national-covid-19-tide-within-weeks/
one quote from this Harvard article.....
"Mina envisions a day when the government sends simple, cheap DIY tests to every home in the United States. Even if half of Americans tested themselves weekly and self-isolated if positive, the result would be profound, he said."
Cwalsh, yes, GDR have Lamp test on the POC instrument....
https://testingmethods.crowdicity.com/post/3167180